Source - SMW
Sareum Holdings posted a first-half loss as it continued to develop its cancer treatment candidates.   Pre-tax losses for the six months through December amounted to £907k, compared to losses of £830k on-year.

The company has yet to book revenue.


At 9:59am: (LON:SAR) Sareum Holdings PLC share price was -0.03p at 0.75p